SELEGILINE USE TO PREVENT PROGRESSION OF PARKINSONS-DISEASE - EXPERIENCE IN 22 DENOVO PATIENTS

被引：59

作者：

ELIZAN, TS ^{[1
]}

YAHR, MD ^{[1
]}

MOROS, DA ^{[1
]}

MENDOZA, MR ^{[1
]}

PANG, S ^{[1
]}

BODIAN, CA ^{[1
]}

机构：

[1] CUNY,MT SINAI MED CTR,DEPT BIOMATH SCI,NEW YORK,NY 10029

来源：

ARCHIVES OF NEUROLOGY | 1989年 / 46卷 / 12期

关键词：

D O I：

10.1001/archneur.1989.00520480017012

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1275 / 1279

页数：5

共 19 条

[1]

BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5

[2] INCREASED LIFE EXPECTANCY RESULTING FROM ADDITION OF L-DEPRENYL TO MADOPAR TREATMENT IN PARKINSONS-DISEASE - A LONGTERM STUDY [J].

BIRKMAYER, W ;

KNOLL, J ;

RIEDERER, P ;

YOUDIM, MBH ;

HARS, V ;

MARTON, J .

JOURNAL OF NEURAL TRANSMISSION, 1985, 64 (02) :113-127

[3] POTENTIATION OF ANTI AKINETIC EFFECT AFTER L-DOPA TREATMENT BY AN INHIBITOR OF MAO-B, DEPRENIL [J].

BIRKMAYER, W ;

RIEDERER, P ;

YOUDIM, MBH ;

LINAUER, W .

JOURNAL OF NEURAL TRANSMISSION, 1975, 36 (3-4) :303-326

[4]

Birkmayer W, 1983, Mod Probl Pharmacopsychiatry, V19, P170

[5] PARGYLINE AND DEPRENYL PREVENT THE NEUROTOXICITY OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN MONKEYS [J].

COHEN, G ;

PASIK, P ;

COHEN, B ;

LEIST, A ;

MYTILINEOU, C ;

YAHR, MD .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 106 (01) :209-210

[6]

Csanda E, 1987, J Neural Transm Suppl, V25, P105

[7] DEPRENYL IN PARKINSON DISEASE [J].

EISLER, T ;

TERAVAINEN, H ;

NELSON, R ;

KREBS, H ;

WEISE, V ;

LAKE, CR ;

EBERT, MH ;

WHETZEL, N ;

MURPHY, DL ;

KOPIN, IJ ;

CALNE, DB .

NEUROLOGY, 1981, 31 (01) :19-23

[8]

Knoll J, 1972, Adv Biochem Psychopharmacol, V5, P393

[9]

KNOLL J, 1988, MT SINAI J MED, V55, P67

[10]

KNOLL J, 1965, ARCH INT PHARMACOD T, V155, P154

← 1 2 →